Incyte (NASDAQ:INCY) reported quarterly earnings results on February 10, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per share of $1.80,…
Incyte (NASDAQ:INCY) reported quarterly earnings results on February 10, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $1.80, missing the consensus estimate of $1.83 by $0.03 per share. Revenue came in at $1.5B, beating the estimate of $1.4B.
Incyte's stock moved following the earnings release. The stock currently trades at $98.22 with a market capitalization of $18.9B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · INCY
$124.64
Down: -$0.46 · -0.37%
Live quote updated
Keep reading
analyst ·
analyst ·
institutional ·
analyst ·
